D.E. Shaw & Co
DTIL icon

D.E. Shaw & Co’s Precision BioSciences DTIL Stock Holding History

D.E. Shaw & Co’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,165
Closed -$52.9K – 4378
2023
Q3 		$52.9K Sell
5,165
-9,323
-64% -$143K ﹤0.01% 3913
2023
Q2 		$229K Sell
14,488
-1,233
-8% -$28.2K ﹤0.01% 3702
2023
Q1 		$355K Buy
15,721
+167
+1% +$5.5K ﹤0.01% 3692
2022
Q4 		$555K Sell
15,554
-1,742
-10% -$68.8K ﹤0.01% 3798
2022
Q3 		$674K Buy
17,296
+8,485
+96% +$403K ﹤0.01% 3858
2022
Q2 		$423K Buy
+8,811
New +$517K ﹤0.01% 4193
2020
Q4 		– Sell
-717
Closed -$133K – 3969
2020
Q3 		$133K Buy
+717
New +$143K ﹤0.01% 3674
2019
Q4 		– Sell
-438
Closed -$110K – 3999
2019
Q3 		$110K Buy
+438
New +$143K ﹤0.01% 3689

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

D.E. Shaw & Co's DTIL Position: Q4 2023 in Review

D.E. Shaw & Co sold out of Precision BioSciences (DTIL) in Q4 2023, closing a stake of 5,165 shares — an estimated $52.9K sold.

D.E. Shaw & Co first reported a position in DTIL in Q3 2019 and held it in 8 quarters. The position peaked at $674K in Q3 2022. 65 funds tracked by Wall St. Rank hold DTIL as of Q4 2023.

  • D.E. Shaw & Co reported no remaining Precision BioSciences position as of Q4 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 5,165 Precision BioSciences shares in Q4 2023, an estimated $52.9K.
  • D.E. Shaw & Co first reported a position in Precision BioSciences in Q3 2019 and held it in 8 quarters.
  • D.E. Shaw & Co's Precision BioSciences position peaked at $674K in Q3 2022.
  • 65 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.